niacinamide has been researched along with Neoplasms, Skull Base in 2 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lebellec, L | 1 |
Chauffert, B | 1 |
Blay, JY | 1 |
Le Cesne, A | 1 |
Chevreau, C | 1 |
Bompas, E | 1 |
Bertucci, F | 1 |
Cupissol, D | 1 |
Fabbro, M | 1 |
Saada-Bouzid, E | 1 |
Duffaud, F | 1 |
Feuvret, L | 1 |
Bonneville-Levard, A | 1 |
Bay, JO | 1 |
Vauleon, E | 1 |
Vinceneux, A | 1 |
Noel, G | 1 |
Penel, N | 1 |
Mir, O | 1 |
Golinelli, G | 1 |
Toso, A | 1 |
Rosa, MS | 1 |
Valletti, PA | 1 |
Pia, F | 1 |
2 other studies available for niacinamide and Neoplasms, Skull Base
Article | Year |
---|---|
Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Child; Chordoma; Erlotinib Hydroc | 2017 |
Skull Base Metastasis From Occult Renal Cell Carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Combined Modality Thera | 2018 |